Should a Woman Be Allowed to Hire a Surrogate Because She Fears Pregnancy Will Hurt Her Career?
By Sarah Elizabeth Richards,
Elle
| 04. 17. 2014
Or "ruin" her body? What if she's just afraid of giving birth?
About three years after they got married, in 2007, wedding photographer Mari Smith* and her husband began batting around the question of when to have kids. “We gotta get started on this,” he’d say.
“I know,” she’d reply. “Just not now.”
A few months shy of Smith’s thirty-seventh birthday, “now” seemed like the worst time ever. After plodding through the recession, her business had finally picked up. She’d come a long way from the early days when she’d made as little as $15,000 a year and had to do family portraits on the side. Now clients booked her months in advance for million-dollar weddings and flew her as far as Thailand and Mexico. Although she and her accountant husband earned a combined income in the low six figures, Smith craved financial stability and was working 60 hours a week to build her brand.
How was she supposed to fit a pregnancy into that schedule? What if she had Kate Middleton’s severe morning sickness? Or a complication such as gestational diabetes or high blood pressure, which were more likely in women...
Related Articles
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By Ilyse Hogue, The Bulwark | 02.20.2026
Since I started working to understand the radicalization of young men, I’ve gotten asked the same question everywhere I go: Are they a lost cause for Democrats? Too redpilled to reach? Too far gone to bring back?
My answer has...